Evidence map›Paper›PMID 38563583›Full record

ArticleHepatology communications2024

Brief alcohol interventions are underutilized in persons with nonalcohol-associated chronic liver diseases.

Jeremy Louissaint, Jonathan Melendez-Torres, Wei Zhang, Julia Kozlitina, Ahmad Anouti, Mausam J Patel, Bill Y Zhang, Amit G Singal, Mack C Mitchell, Thomas G Cotter

Open access · goldAbstract read
In one paragraph

Article in Hepatology communications, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.3field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Jeremy LouissaintDepartment of Internal Medicine, Division of Digestive and Liver Diseases, University of Texas Southwestern Medical Center, Dallas, Texas, USA.ORCID 0000-0003-1154-1825
Jonathan Melendez-TorresDepartment of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
Wei ZhangDepartment of Internal Medicine, Division of Gastroenterology, Alcohol Liver Center, Massachusetts General Hospital, Boston, Massachusetts, USA.
Julia KozlitinaDepartment of Internal Medicine, The Eugene McDermott Center for Human Growth and Development, University of Texas Southwestern, Dallas, Texas, USA.
Ahmad AnoutiDepartment of Internal Medicine, Division of Digestive and Liver Diseases, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
Mausam J PatelDepartment of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
Bill Y ZhangUniversity of Texas Southwestern Medical School, Dallas, Texas, USA.
Amit G SingalDepartment of Internal Medicine, Division of Digestive and Liver Diseases, University of Texas Southwestern Medical Center, Dallas, Texas, USA.ORCID 0000-0002-1172-3971
Mack C MitchellDepartment of Internal Medicine, Division of Digestive and Liver Diseases, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
Thomas G CotterDepartment of Internal Medicine, Division of Digestive and Liver Diseases, University of Texas Southwestern Medical Center, Dallas, Texas, USA.ORCID 0000-0002-0376-0107
The University of Texas Southwestern Medical Center · USHarvard University · US

Funding

Multi-level Evaluation of Racial/ethnic Disparities in Liver Disease OutcomesR01CA256977 · NCI · BAYLOR COLLEGE OF MEDICINE · PI KANWAL, FASIHA, SINGAL, AMIT · 2021 to 2025
$3.0M
Integrated therapies for alcohol use and ALD (ITAALD) Network – UTSW Clinical CenterU01AA026975 · NIAAA · UT SOUTHWESTERN MEDICAL CENTER · PI E SHERWOOD BROWN, Mack Clarence Mitchell · 2018 to 2026
$3.0M
Determining the Influence of Clinicodemographic, Biologic and SDOH Factors in Racial and Ethnic Disparities in the Prognosis of Alcohol-Associated Liver DiseaseK23AA031310 · NIAAA · UT SOUTHWESTERN MEDICAL CENTER · PI COTTER, THOMAS GERARD · 2023 to 2025
$580k
NCI NIH HHS R01 CA256977NIAAA NIH HHS K23 AA031310NIAAA NIH HHS U01 AA026975
6 · The paper itself

Abstract

backgroundBrief alcohol interventions use patient-provider communication to promote alcohol cessation. We characterized the receipt of this intervention in chronic liver disease (CLD).

methodsWe surveyed patients with CLD for weekly drinking patterns and examined associations with patient-provider communication receipt.

resultsAmong 840 participants, 82.1% and 56.5% reported ≥1 standard drink weekly and excessive alcohol consumption, respectively. Patient-provider communication was lower in noncirrhotic (adjusted odds ratio:0.34, 95% CI: 0.22-0.54) and nonalcohol-associated CLD (adjusted odds ratio: 0.22, 95% CI: 0.15-0.34) among individuals drinking ≥1 standard drink weekly, and similarly in noncirrhotic CLD (adjusted odds ratio: 0.45, 95% CI: 0.21-0.95) among those with excessive drinking.

conclusionsBrief alcohol interventions are underutilized in noncirrhotic and nonalcohol-associated CLD.

Indexed as

Alcohol DrinkingLiver DiseasesHealth BehaviorHumansSurveys and Questionnaires

Identifiers

PMID38563583
PMCPMC10990407
OpenAlexW4393411052

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.